Preventing renal failure employing nicotinic acid

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31455

Patent

active

044724101

ABSTRACT:
A method and substances are featured for reducing the risk of incurring renal damage or failure. Substances useful in the treatment of hyperlipidemia and closely-related vascular conditions have been found to reduce or prevent renal failure. The substances most generally utilized are derivatives of phenoxyacetic acid. These substances are administered from 0.01 to 0.25% by weight of the dietary materials ingested by the host which is equivalent to 0.2 to 6.0 grams per day in man.

REFERENCES:
Edwards et al.; Med. J. Aust. (1972) 2, p. 167.
Edwards et al.; Lancet, (1973) 1, p. 1192.
Ibels et al.; British Med. Journal, pp. 552-554 (1976).
Issekutz; Canadian Journal of Physiology+Pharmocology, vol. 49 (1971), pp. 102-105.
Edwards et al.; Aust. NZJ. Med. 4:420 (1976).
Edwards, Artery; 3(2) 135-149 (1977).
Issekutz; C.A. vol. 74 (1971) 110013s.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Preventing renal failure employing nicotinic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preventing renal failure employing nicotinic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing renal failure employing nicotinic acid will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-793828

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.